APOBEC3B and urinary bladder cancer: Additionally, Middlebrooks and colleagues [41] showed that the effect of the APOBEC3B deletion on bladder cancer is mostly driven by SNP rs1014971 [being in linkage disequilibrium (LD) with the deletion], and mostly disappears after adjustment for this SNP genotype [OR(95%CI)=0.88(0.72-1.07), p=0.21 and 0.96(0.79-1.16), p=0.67 in European and Japanese populations, respectively].